Henry Mauricio Chaparro-Solano

Has grant

Director de Investigaciones

Universidad Autónoma de Bucaramanga
No Info

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Identification of variants in the SARS-CoV-2 viral genome by massively parallel sequencing and their correlation with clinical outcomes of COVID-19: Epidemiological surveillance of genomic and clinical behavior in the epicenters of the pandemic in Colombia.

Open Date:

Close Date:

Articles (10)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Knowledge of the genetic factors in normal pressure hydrocephalus (NPH) is rapidly evolving, with significant advances in recent years. We conducted a systematic review examining genetic contributions to NPH risk. Ovid Embase, Ovid Medline, Web of Science, and Cochrane Central were searched from inception through October 14, 2024, for human studies in English reporting familial NPH cases, genetic variants associated with NPH, and associations with other neurogenetic disorders and exploring transcriptomics. Studies on secondary, obstructive, and congenital hydrocephalus were excluded, and findings were reported narratively. Of 2562 titles and abstracts screened, 56 met inclusion criteria, predominantly involving European populations. More than 30 familial cases were identified, and two cohorts found that 10%–16% of patients with NPH had relatives with NPH symptoms. Whole‐genome/exome sequencing, copy‐number variant analyses, and genome‐wide association studies showed risk variants enriched in NPH cohorts in or near CFAP43 , SFMBT1 , CWH43 , AK9 , RXFP2 , PRKD1 , HAVCR1 , OTOG , MYO7A , NOTCH1 , SPG11 , MYH13 , FOXJ1 , AMZ1/GNA12 , and C16orf95 , alongside protective variants near SLCO1A2 and MLLT10 . These genes are associated with blood‐brain and blood–cerebrospinal fluid barriers, cilia, and ependymal function. In addition, higher rates of pathological C9orf72 repeat expansions were observed in an NPH cohort compared with controls. NPH was also more prevalent in frontotemporal dementia cohorts without this expansion and co‐occurred with myotonic dystrophy type 1 in several cases. Despite heterogeneity in outcome measures, this review highlights the genetic contribution to NPH risk. Future research should encourage collaborations for big data generation, identify genetic variants addressing diversity, and integrate clinical, environmental, and shunt‐response data. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Year:

2025

Variants in PGLYRP2 , particularly rs892145-T, have been suggested as Parkinson’s disease (PD) risk factors. We analyzed data from 31,334 PD patients and 17,772 controls across diverse ancestries. A significant sex-dependent effect of rs892145-T was observed in African (AFR) ancestry males (OR=0.73, 95%CI: 0.57-0.94, p=0.014). Gene-based analyses identified another variant, rs7251871-A, as significantly associated with PD in AFR males (OR=1.34, 95%CI:1.13-1.59, p=6.65E-04, Bonferroni p=0.0432). No associations were observed in other ancestries. Further studies are needed to understand PGLYRP2’s role in PD. Plain language summary (PLS) Genetic variations in the PGLYRP2 gene have been linked to the risk of developing Parkinson’s disease (PD), but the research reports have been inconclusive. In this study, we therefore investigated whether genetic variants in this gene are associated with PD. We analyzed data from 32,334 people with PD and 17,772 people without the disease, all from diverse ancestral backgrounds. We found that a previously reported genetic variant, called rs892145-T, appeared to have a possible protective effect against PD specifically in males of African descent. We also identified a different variant, rs7251871-A, which had not been linked to PD before, that seemed to increase PD risk in the same group. No significant results were found in other ancestry groups or for the females group. These findings need to be confirmed in future studies with larger numbers of participants to better understand the role of the gene PGLYRP2 in PD.

Year:

2025

Background Although levodopa remains the gold standard treatment for Parkinson’s disease (PD), its chronic use is associated with levodopa-induced dyskinesia (LID), a motor complication that impacts prognosis, quality of life, and treatment costs. Most known LID-associated factors have been identified in European-descendant populations. Objectives To describe the epidemiology of LID in Latin American and Caribbean (LATAM) countries and assess the relevance of known and novel LID-associated factors in this population. Methods We conducted a cross-sectional study using data from the Latin American Research consortium on the Genetics of Parkinson’s Disease (LARGE-PD). We included PD patients with information on LID status and levodopa use from eight LATAM countries. LID prevalence was calculated overall and by country. Countries were compared on demographic and clinical variables. Logistic regression was used to identify associations with LID. Results A total of 3,695 PD patients (58.8% male) were included. Overall LID prevalence was 25.4% [95% CI: 24.06–26.87], ranging from 9.3% in Colombia to 45.1% in Puerto Rico. Prevalence increased progressively with longer disease duration. Country comparisons showed that not all known LID-associated factors explained prevalence differences. In logistic regression, fast disease progression was significantly associated with LID (OR: 1.55, 95%CI: 1.16–2.07), while sex was not (OR: 1.02, 95%CI: 0.87–1.18). Conclusions This is the largest study on LID epidemiology in LATAM. While some known risk factors remain relevant, others, like sex, do not, underscoring the need for population-specific studies. Future work should integrate environmental, clinical, and genetic data to better understand LID mechanisms.

Year:

2025

Year:

2023

Collaborators (5)

Thiago Peixoto Leal

Senior Scientist

Morehouse School of Medicine

UNITED STATES
View details

Sarael Alcauter

Associate Professor

National Autonomous University of Mexico

View details

Ignacio Fernandez Mata

Associate Staff

Cleveland Clinic

UNITED STATES
View details

Daniel Martinez-Ramirez

Clinical and Research Professor

Tecnológico de Monterrey

View details

Leila Saadatpour

Assistant Professor

University of Texas Health Science Center at San Antonio

UNITED STATES
View details